The FDA just approved a new treatment for early-stage breast cancer called Perjeta. It's different than most treatments out there because patients get it before surgery, not after.

Dr. Robyn Young, a medical oncorlogist at the Center for Cancer and Blood Disorders in Fort Worth, joined News 8 at 4 to talk about the new drug.

Read or Share this story: